Navigation Links
OPKO Health To Acquire PROLOR Biotech
Date:4/23/2013

ny of PROLOR's compounds under development may fail, may not achieve the expected results or effectiveness and may not generate data that would support the approval or marketing of products for the indications being studied or for other indications, that currently available products, as well as products under development by others, may prove to be as or more effective than PROLOR's products for the indications being studied, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in OPKO's and PROLOR's filings with the Securities and Exchange Commission, the ability to obtain regulatory approvals for the transaction on the proposed terms and schedule; the failure of OPKO's or PROLOR's stockholders to approve the transaction; the risk that a condition to closing of the merger may not be satisfied; the time required to consummate the proposed merger; the focus of management on merger-related issues; the risk that the businesses will not be integrated successfully; the risk that any potential synergies from the transaction may not be fully realized or may take longer to realize than expected; new information arising out of clinical trial results; and the risk that the safety and/or efficacy results of existing clinical trials will not support continued clinical development, as well as risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new pr
'/>"/>
SOURCE OPKO Health, Inc.; PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. California Healthcare Institute Announces Executive Promotion
2. Healthcare Sales Hiring Slowly on the Rise
3. Bayer CropScience Promotes Bee Health Awareness and Collaboration
4. A Prescription for an Ailing Health Care System
5. Kitware to Develop a Universal Healthcare Exchange Language Infrastructure
6. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
7. Start a Healthy Tradition this Earth Day: Tips from Topical BioMedics on How to Detox the Family Medicine Cabinet
8. TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
9. Online Courses Address Latest Healthcare Compliance Regulations
10. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
11. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Research and Markets  has announced the addition ... Industry Analysis, Size, Share, Growth, Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection is a ... RNA) into cells. This technology helps the cells to ... metabolism by affecting the nuclear genes. The transfection technology ...
(Date:7/11/2014)... July 11, 2014 Cayenne Medical, ... specializing in the soft tissue reconstruction segment, announced ... System for surgeries involving the shoulder and extremities. ... a novel, inserter-controlled deployment method. The unique delivery ... deployment, anchor pull-out, or anchor displacement (also commonly ...
(Date:7/10/2014)... Boston, Mass. (PRWEB) July 10, 2014 ... , today announced that Alan Swahn, a former vice ... Terascala’s executive team as vice president of marketing. Terascala’s ... from Dell and NetApp create the highest performance and ... has been appointed to guide Terascala’s channel expansion and ...
(Date:7/10/2014)... Senior supply chain management executives from over 50 ... of “Reducing Cost, Lead Time, & Defects in the ... the partnership of the Bio Supply Management Alliance ( ... SCMI) of the University of San Diego in ... Institute of Peace and Justice in San Diego, Devendra ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4
... saliva can be used to quickly and effectively screen for ... children, says research in the June 2 issue of the ... at the University of Alabama at Birmingham (UAB) found saliva ... samples were used, and 97.4 percent of babies when the ...
... curtain about to rise on a much-anticipated new era of ... for food, fuel, and other uses scientists are reporting a ... corn, tomatoes, rice and other food crops. Their article appears ... Jorge Gardea-Torresdey and colleagues at The University of Texas ...
... 2011 VWR International, LLC, a global leader ... that it acquired the business of BioExpress Corp. ... in 1985, BioExpress is a well-respected distributor in ... offers over 200 well-known, multi-national brands, including its ...
Cached Biology Technology:Saliva is effective in screening for CMV infection in newborns, says NIH-funded research 2Saliva is effective in screening for CMV infection in newborns, says NIH-funded research 3VWR International, LLC Acquires BioExpress Corp. 2
(Date:7/11/2014)... 2014 Researchers have pioneered a revolutionary new ... technology, called Virtual Finger, allows scientists to move ... and synapses using the flat surface of their ... imaging studies orders of magnitude more efficient, saving ... across many areas of experimental biology. The software ...
(Date:7/11/2014)... receptor type 1 can inhibit voltage-gated calcium ... neurotransmitter release. However, some scholars demonstrated that ... Ca2+ influx and increase neurotransmitter release. Dr. ... Affiliated to Tongji Medical College, Huazhong University ... cell voltage-clamp and calcium imaging in cultured ...
(Date:7/10/2014)... 27, 2014  The American Academy of Forensic ... Standards and Technology (NIST) and the Department of ... and forensic science expert members to the Forensic ... element of the NIST,s Organization of Scientific Area ... first appointments made to the new FSSB that ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3
... that the first antibiotics were discovered almost a century ... are still serious diseases for humans in the twenty-first ... are more than 8 million new cases of tuberculosis ... than 300,000 of these are due to multidrug-resistant strains ...
... Illinois anthropology professor Ripan Malhi looks to ... to the Americas and what happened to them once they were ... meeting, " Ancient DNA: The First Three Decades ," at The ... an affiliate of the Institute for Genomic Biology at Illinois ...
... a gene associated with a high risk of severe ... actual cause of this form of asthma, a leading ... is a complex disease, with multiple interacting causes, we ... ages two and six," said co-lead author of the ...
Cached Biology News:Bacteria use lethal cytotoxins to evade antibiotic treatment 2Ancient, modern DNA tell story of first humans in the Americas 2Novel gene variant found in severe childhood asthma 2
Request Info...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
TGF-beta 1,-2,-3 MAb (Clone 1D11)...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
Biology Products: